000			01451 a2200397 4500
005			20250511180556.0
264		0	_c19921231
008			199212s 0 0 eng d
022			_a0344-5704
024	7		_a10.1007/BF00685105 _2doi
040			_aNLM _beng _cNLM
100	1		_aMiller, A A
245	0	0	_aPharmacodynamics of three daily infusions of etoposide in patients with extensive-stage small-cell lung cancer. _h[electronic resource]
260			_bCancer chemotherapy and pharmacology _c1992
300			_a161-6 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aCarcinoma, Small Cell _xblood
650	0	4	_aCisplatin _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aEtoposide _xadministration & dosage
650	0	4	_aHematologic Diseases _xchemically induced
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xblood
650	0	4	_aMetabolic Clearance Rate
650	0	4	_aMiddle Aged
650	0	4	_aModels, Statistical
700	1		_aTolley, E A
700	1		_aNiell, H B
700	1		_aStewart, C F
700	1		_aGriffin, J P
773	0		_tCancer chemotherapy and pharmacology _gvol. 31 _gno. 2 _gp. 161-6
856	4	0	_uhttps://doi.org/10.1007/BF00685105 _zAvailable from publisher's website
999			_c1339892 _d1339892